Skip to content
All news
Analysis

Is Teladoc Health Stock 40% Undervalued?

A Discounted Cash Flow (DCF) model suggests Teladoc Health stock trades at a 40% discount to its intrinsic value. This comes as insurance coverage for virtual care expands, potentially boosting demand.

July 9, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

share price decline 5yr
93.9%
discount to intrinsic value
40%

According to an analysis by Simply Wall St, Teladoc Health (TDOC) stock may be undervalued by as much as 40%, as insurance coverage for virtual healthcare expands.

Recommendation Change

No specific analyst recommendation change was mentioned in the article, but the analysis indicates the stock trades at a significant discount to its estimated intrinsic value via DCF.

Analyst Rationale

The valuation is based on a Discounted Cash Flow (DCF) model, which estimates the stock's intrinsic value at about 40% above its current price. Additionally, the stock's 93.9% decline over five years makes it sensitive to any positive shift in market expectations.

Context

Expanding insurance coverage for virtual care is a potential catalyst for revenue growth, as more insurers cover Teladoc's services. However, the article did not mention other analysts' views.

What to Make of It

While the analysis suggests a pricing opportunity, investors should consider risks in the telehealth sector, including competition and regulatory changes.

Frequently Asked Questions

Teladoc Health is a telehealth company providing virtual medical consultations.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.